Hae Young Ahn

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Immunogenicity assessment is important for biological products due to potential impacts of immunogenicity on safety and efficacy. We reviewed the prescribing information and the FDA’s clinical pharmacology review of 121 approved biological products for evaluating and reporting of immunogenicity data. Of the 121 products, 89% (n = 108) reported the incidence(More)
  • 1